BioNxt Solutions Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	58	78	43	52	54	84
Market Cap Growth	22.81%	81.91%	-17.23%	-3.25%	-35.83%	-27.96%
Enterprise Value	64	86	49	56	57	86
Last Close Price	0.45	0.64	0.38	0.48	0.59	1.08
PS Ratio	-	-	1596.92	139.87	180.92	292.73
PB Ratio	-6.23	-8.37	-5.48	-9.86	-13.03	50.26
EV/Sales Ratio	-	-	1801.99	151.45	191.00	301.49
Debt / Equity Ratio	-0.63	-0.63	-0.54	-0.93	-1.06	3.27
Net Debt / Equity Ratio	-0.63	-0.63	-0.54	-0.86	-1.03	2.46
Net Debt / EBITDA Ratio	-0.99	-0.99	-0.97	-0.73	-0.66	-0.26
Net Debt / FCF Ratio	-1.13	-1.13	-1.40	-0.84	-0.68	-0.33
Asset Turnover	-	-	0.03	0.26	0.05	0.03
Quick Ratio	0.02	0.02	0.01	0.10	0.30	0.35
Current Ratio	0.05	0.05	0.02	0.11	0.34	0.50
Return on Equity (ROE)	-	-	-	-	-	-727.39%
Return on Assets (ROA)	-638.57%	-638.57%	-303.04%	-276.01%	-72.47%	-112.53%
Return on Capital Employed (ROCE)	110.20%	110.20%	70.60%	120.40%	1624.10%	-379.10%
Earnings Yield	-12.05%	-8.96%	-12.33%	-14.83%	-23.00%	-24.61%
FCF Yield	-	-6.63%	-7.04%	-10.31%	-11.58%	-15.03%
Buyback Yield / Dilution	-6.04%	-6.04%	-12.17%	-18.56%	-19.28%	-22.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.